EU's CHMP recommends NeurogesX's Qutenza for non-diabetic neuropathic pain
20 March 2009
Katie McQue
NeurogesX's analgesic Qutenza (capsaicin) has received a positive opinion from the EU's
CHMP for the treatment of neuropathic pain in non-diabetic adults, either as monotherapy, or as an adjunct to other analgesics.
According to the committee, the benefits of Qutenza are its ability to reduce...
Please Login to read the full article.
20 March 2009
Katie McQue
According to the committee, the benefits of Qutenza are its ability to reduce...
Please Login to read the full article.
RELATED CONTENT
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
